| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/13/2006 | WO2006038456A1 Biomaterial construct, its producing method, biomaterial support, target material purifying method, affinity chromatography container, separation chip, analyzing method and analyzing separator for target material, biomaterial complex, and its support, sensor chip, solid support with biomaterial fixed thereon |
| 04/13/2006 | WO2006038212A2 Methods and compositions for the diagnosis and treatment of cancer |
| 04/13/2006 | WO2006038022A1 Methods for antibody library screening |
| 04/13/2006 | WO2006038010A2 Detection of breast cancer |
| 04/13/2006 | WO2006037993A2 Cancer markers |
| 04/13/2006 | WO2006037992A1 Apparatus and method for measuring hydrogen concentration in molten metals |
| 04/13/2006 | WO2006037837A1 Dye particle and its preparation and use |
| 04/13/2006 | WO2006037830A1 Detector for the predictive diagnosis of faults in medium- and high-power gear boxes and reducers |
| 04/13/2006 | WO2006037800A1 COMPLEMENTARY PEPTIDES FOR ß-AMYLOID 29-42 PEPTIDE |
| 04/13/2006 | WO2006037657A2 Quadruple transformed cell line useful for the identification of transport inhibitors |
| 04/13/2006 | WO2006037622A1 Screening process for the detection and characterization of protein-protein-interactions in vivo by fluorescence cross correlation spectroscopy |
| 04/13/2006 | WO2006037604A1 Novel antibodies directed to the mammalian eag1 ion channel protein |
| 04/13/2006 | WO2006037573A1 Type pept1 protein assay |
| 04/13/2006 | WO2006037570A2 Protein assay of type sglt1 |
| 04/13/2006 | WO2006037569A1 Protein assay of type eaac1 |
| 04/13/2006 | WO2006037527A1 Masked solid porous supports allowing fast and easy reagent exchange to accelerate electrode-based microarrays |
| 04/13/2006 | WO2006037521A1 Identifying gastrokine 1 (gkn1) as a biomarker for inflammations and infections |
| 04/13/2006 | WO2006037513A1 Diagnostics and therapeutics for diseases associated with matrix metalloproteinase 9 (mmp9) |
| 04/13/2006 | WO2006037495A2 Diagnostics and therapeutics for diseases associated with nuclear receptor subfamily 3, group c, member 2 (nr3c2) |
| 04/13/2006 | WO2006037485A2 Methods and kits for the prediction of therapeutic success and recurrence free survival in cancer therapy |
| 04/13/2006 | WO2006037462A2 Cancer markers |
| 04/13/2006 | WO2006037421A2 Immunogenic t-helper epitopes from human tumour antigens and immunotherapeutic methods using said epitopes |
| 04/13/2006 | WO2006037229A1 Formulation of multivalent antibody constructs and use of same for cancer therapy |
| 04/13/2006 | WO2006021451A3 Methods and compounds for treating diabetes |
| 04/13/2006 | WO2006021343A3 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine receptor 3a (5-ht3a) |
| 04/13/2006 | WO2006018849A3 Non-invasive prenatal genetic diagnosis using transcervical cells |
| 04/13/2006 | WO2006014755A3 Methods of identifying patients at risk of developing encephalitis following immunotherapy for alzheimer’s disease |
| 04/13/2006 | WO2006011640A8 Method for analyzing oligomeric proanthocyanidin (opc) |
| 04/13/2006 | WO2006010515A3 Diagnostics and therapeutics for diseases associated with 5-hydroxytryptamine 2a receptor (5ht2a) |
| 04/13/2006 | WO2006008401A3 Composition containing a photosynthetic marine and/or fresh-water microorganism culture medium and/or |
| 04/13/2006 | WO2006008267A3 Methods for optimizing forming viiia-based hemostatic treatment |
| 04/13/2006 | WO2006008002A3 Diagnostics and therapeutics for diseases associated with kallikrein 1 (klk1) |
| 04/13/2006 | WO2006003397A3 Membrane fusion assay |
| 04/13/2006 | WO2005124351A3 A sensitive antibody-based method for detecting cryptosporidium parvum oocysts in water |
| 04/13/2006 | WO2005121799A3 Non-covalent complexes comprising carbon nanotubes |
| 04/13/2006 | WO2005121374A3 Molecular analysis of hair follicles for disease |
| 04/13/2006 | WO2005118832A3 Diagnostics and therapeutics for diseases associated with serum/glucocorticoid regulated kinase-like protein (sgkl) |
| 04/13/2006 | WO2005117998A3 Smvt transporters expressed in cancer cells |
| 04/13/2006 | WO2005117952A3 Treatment methods utilizing albumin-binding proteins as targets |
| 04/13/2006 | WO2005117897A3 Hepoxilins and modulators of ichthyin for treatment skin disorders |
| 04/13/2006 | WO2005116650A3 High throughput discovery of materials through vapor phase synthesis |
| 04/13/2006 | WO2005114180A3 Functional ghs-r antagonists |
| 04/13/2006 | WO2005110460A3 Diagnosis and treatment methods related to aging, especially in muscle (14.1) |
| 04/13/2006 | WO2005108604A3 Device and method for detecting molecular interactions |
| 04/13/2006 | WO2005103698A3 Methods and antibodies for nitrofuran detection |
| 04/13/2006 | WO2005100405A3 Phosphorylcholine conjugates and corresponding antibodies |
| 04/13/2006 | WO2005095632A3 Methods for identifying proteins with starch phosphorylating enzymatic activity |
| 04/13/2006 | WO2005093429A3 Method for the detection of intracellular parameters with luminescent protein probes for the screening of molecules capable of altering said parameters |
| 04/13/2006 | WO2005090986A3 Analysis of saccharide vaccines without interference |
| 04/13/2006 | WO2005083118A3 Pin-prc transition genes |
| 04/13/2006 | WO2005080430A3 Anti-ube4a/ufd2b polyclonal antibody and its use thereof as diagnostic and prognostic marker of 11q23 region alterations |
| 04/13/2006 | WO2005059692A3 Processing and managing genetic information |
| 04/13/2006 | WO2005059511A3 Densitometer with pulsing pressure |
| 04/13/2006 | WO2005051319A3 Plks as modifiers of the beta catenin pathway and methods of use |
| 04/13/2006 | WO2005042759A3 Expression profiling using microarrays |
| 04/13/2006 | WO2005041758A3 Novel cell-based assays employing voltage and calcium dyes |
| 04/13/2006 | WO2005031584A3 Using multiple perturbations to elucidate connectivity in network systems |
| 04/13/2006 | WO2005028662A3 Test strip and method for determining ldl cholesterol concentration from whole blood |
| 04/13/2006 | WO2005014850A3 Systems and methods for analyzing nucleic acid sequences |
| 04/13/2006 | WO2005014847A3 Reagents, methods and kits for detecting feed enzymes |
| 04/13/2006 | WO2005012876A3 Methods of screening compositions for g protein-coupled receptor desensitization inhibitory activity |
| 04/13/2006 | WO2004019882A3 METHODS OF SCREENING FOR COMPOUNDS THAT MODULATE TAFIa ACTIVITY, COMPOUNDS, AND METHODS OF USING THE COMPOUNDS |
| 04/13/2006 | US20060080744 Novel chemokine-like polypeptides |
| 04/13/2006 | US20060080152 Modular microprocessor-based appliance system |
| 04/13/2006 | US20060080073 Three-dimensional structural activity correlation method |
| 04/13/2006 | US20060080042 Method of non-targeted complex sample analysis |
| 04/13/2006 | US20060079811 Test media cassette for bodily fluid testing device |
| 04/13/2006 | US20060079806 Method and apparatus for measuring factors in mammary fluids |
| 04/13/2006 | US20060079670 98 human secreted proteins |
| 04/13/2006 | US20060079580 Production of mutant strain of aspergillus fumigatus, method of assay for inhibiting siderophore biosynthesis and diagnostic method for detecting likely aspergillus fumigatus infection |
| 04/13/2006 | US20060079493 Such as rheumatoid arthritis or cancer, with HSP90 inhibitor such as 17-allylaminogeldanamycin (17-AAG), geldanamycin, herbimycin A, and macbecin; pharmacogenetics |
| 04/13/2006 | US20060079488 Methods of treating and preventing bone loss |
| 04/13/2006 | US20060079445 CaMKII/calcium channel binding-related compositions and methods |
| 04/13/2006 | US20060079439 Elastin prevents occlusion of body vessels by vascular smooth muscle cells |
| 04/13/2006 | US20060079001 Local flow and shear stress sensor based on molecular rotors |
| 04/13/2006 | US20060079000 Capture and detection of microbes by membrane methods |
| 04/13/2006 | US20060078985 Device and method for quantitatively measuring immobilized sample |
| 04/13/2006 | US20060078984 Sensors for biomolecular detection and cell classification |
| 04/13/2006 | US20060078975 Crystal structure of enzyme and uses thereof |
| 04/13/2006 | US20060078961 Microfluidic systems for altering the solution environment around a nanoscopic or microscopic object, such as a sensor; applied in any sensor technology in which the sensing element needs to be exposed rapidly, sequentially, and controllably, to a large number of different solution environments |
| 04/13/2006 | US20060078960 Expression quantification using mass spectrometry |
| 04/13/2006 | US20060078958 Method of multiple quantification of cholesterol in low-density lipoproteins |
| 04/13/2006 | US20060078957 A host cell containing an expression vector for an aggrecanase to use as a drug screening agent for joint diseases |
| 04/13/2006 | US20060078956 Methods to identify compounds that modulate rage |
| 04/13/2006 | US20060078955 Method for retrieving delta9-THC from oral fluid |
| 04/13/2006 | US20060078954 Device and Method to Simultaneously Detect Different Antibodies and Antigens in Clinical Alimentary and Environmental Samples |
| 04/13/2006 | US20060078953 Epad, an oocyte specific protein |
| 04/13/2006 | US20060078952 Method for identifying antimicrobial molecules which interfere with apolipoprotein N-acyltransferase activity |
| 04/13/2006 | US20060078951 Monoclonal antibody selectively recognizing listeria monocytogenes, hybridoma producing the antibody, test kit comprising the antibody and detection method of listeria monocytogenes using the antibody |
| 04/13/2006 | US20060078950 Identification of Porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases |
| 04/13/2006 | US20060078949 Analyzing immature reticulocytes for the presence of micronuclei; contacting a sample with reticulocyte surface protein antibody coated, flow cytometry-compatible magnetic beads; applying a magnetic field; segregating antibody-bound reticulocytes; labeling magnetic bead-bound reticulocytes |
| 04/13/2006 | US20060078948 Analytical method, analytical instrument, microarray and immunoassay of biological samples |
| 04/13/2006 | US20060078947 Methods and compositions for treating hematological disorders using 9118, 990, 17662, 81982, 630, 21472, 17692, 19290, 21620, 21689, 28899, 53659, 64549, 9465, 23544, 7366, 27417, 57259, 21844, 943, 2061, 5891, 9137, 13908, 14310, 17600, 25584, 27824, 28469, 38947, 53003, 965, 56639, 9661, 16052, 1521, 6662, 13913, 12405 or 5014 |
| 04/13/2006 | US20060078946 Method for manufacturing antigen-specific antibody-producing hybridomas employing a single antigen-specific B lymphocyte and method for manufacturing monoclonal antibody |
| 04/13/2006 | US20060078945 Complex formed by N-linked glycoproteins (SIBLINGS) and Factor H |
| 04/13/2006 | US20060078944 Methods and reagents relating to inflammation and apoptosis |
| 04/13/2006 | US20060078943 Method for obtaining anti-idiotype antibodies |
| 04/13/2006 | US20060078941 Gene expression profiling in primary ovarian serous papillary tumors and normal ovarian epithelium |
| 04/13/2006 | US20060078940 21132, a human G-protein coupled receptor family member and uses therefor |
| 04/13/2006 | US20060078939 Biochip substrate |